# DSP-3025 A Phase 1 Study of Healthy Male Volunteers

> **NCT01124396** · — · COMPLETED · sponsor: **Sumitomo Pharma Co., Ltd.** · enrollment: 24 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** DSP-3025
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01124396
- **Lead sponsor:** Sumitomo Pharma Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2010-04
- **Primary completion:** 2010-08
- **Final completion:** 2012-04
- **Target enrollment:** 24 (ACTUAL)
- **Last updated:** 2022-04-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01124396

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01124396, "DSP-3025 A Phase 1 Study of Healthy Male Volunteers". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT01124396. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*